Vitamins C and E inhibit O2- production in the pig coronary artery

Circulation

Volumn 96, Issue 10, 1997, Pages 3593-3601

  Nunes, Gilberto L ^b,c   Robinson, Keith ^b   Kalynych, Anna ^b   King III, Spencer B ^b   Sgoutas, Demetrios S ^b,c   Berk, Bradford C ^a,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidants; Free radicals; Restenosis; Vasculature

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; FREE RADICAL;

ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RESPONSE; CHOLESTEROL DIET; CORONARY ARTERY; HYPERCHOLESTEROLEMIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; OXIDATIVE STRESS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; SWINE;

EID: 0030831547     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.10.3593     Document Type: Article

References (51)

1. Halliwell B. Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis. Br J Exp Pathol. 1989;70:737-757.
2. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci U S A. 1987;84:7725-7729.
3. Sasahara M, Raines EW, Chait A, Carew TE, Steinberg D, Wahl PW, Ross R. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol, I: Is the extent of atherosclerosis related to resistance of LDL to oxidation? J Clin Invest. 1994;94:155-164.
4. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449.
5. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328:1450-1456.
6. Flaherty JT, Weisfeldt ML. Reperfusion injury. Free Radic Biol Med. 1988;5:409-419.
7. Roberts MJD, Young IS, Trouton TG, Trimble ER, Khan MM, Webb SW, Wilson CM, Patterson GC, Adgey AAJ. Transient release of lipid peroxides after coronary artery balloon angioplasty. Lancet. 1990;336:143-145.
8. Freyschuss A, Stiko RA, Swedenborg J, Henriksson P, Bjorkhem I, Berglund L, Nilsson J. Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits. J Clin Invest. 1993;91:1282-1288.
9. Schneider JE, Berk BC, Gravanis MB, Santoian EC, Cipolla GD, Tarazona N, Lassegue B, King SB III. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury: a possible role for antioxidants in restenosis. Circulation. 1993;88:628-637.
10. Nunes GL, Sgoutas DS, Redden RA, Sigman SR, Gravanis MB, King SB III, Berk BC. Combination of vitamins C and E alters the response to coronary balloon injury in the pig. Arterioscler Thromb Vase Biol. 1995;15:156-165.
11. Konneh MK, Rutherford C, Li SR, Anggard EE, Ferns GA. Vitamin E inhibits the intimal response to balloon catheter injury in the carotid artery of the cholesterol-fed rat. Atherosclerosis. 1995;113:29-39.
12. Lafont AM, Chai YC, Cornhill JF, Whitlow PL, Howe PH, Chisolm GM. Effect of alpha-tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis. J Clin Invest. 1995;95:1018-1025.
13. DeMaio SJ, King SB III, Lembo NJ, Roubin GS, Hearn JA, Bhagavan HN, Sgoutas DS. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA). J Am Coll Nutr. 1992;11:68-73.
14. Tardif J-C, Cote G, Lesperance J, Bourassa M, Bilodeau M, Doucet S, Tanguay J-F, deGuise P, Dupont C. Prevention of restenosis by pre and post-PTCA probucol therapy: a randomized clinical trial. Circulation. 1996;94(suppl I):I-91. Abstract.
15. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995;332:488-493.
16. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 1993;91:2546-2551.
17. Mulvany MJ, Baumbach GL, Aalkjaer C, Heagerty AM, Korsgaard N, Schiffrin EL, Heistad DD. Vascular remodeling. Hypertension. 1996;28:505-506.
18. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995:332:481-487.
19. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316:1371-1375.
20. Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target? J Am Coll Cardiol. 1995;25:516-520.
21. Langille BL, O'Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science. 1986;231:405-407.
22. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activation in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
23. 2 for platelet-derived growth factor signal transduction. Science. 1995;270:296-299.
24. Braude R, Kon SK, Porter JWG. Studies in the vitamin C metabolism of the pig. Br J Nutr. 1950;4:186-199.
25. Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH, Simonet L, Wilcox JN. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation. 1996;93:2178-2187.
26. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916-1923.
27. Lee W, Roberts SM, Labbe RF. Ascorbic acid determination with an automated enzymatic procedure. Clin Chem. 1997;43:154-157.
28. Vatassery GT. In vitro oxidation of alpha-tocopherol (vitamin E) in human platelets upon incubation with unsaturated fatty acids, diamide and superoxide. Biochim Biophys Acta. 1987;926:160-169.
29. Jacob RA. Assessment of human vitamin C status. J Nutr. 1990;11:1480-1485.
30. Bui MH, Sauty A, Collet F, Leuenberger P. Dietary vitamin C intake and concentrations in the body fluids and cells of male smokers and nonsmokers. J Nutr. 1992;122:312-316.
31. Reidy MA. Proliferation of smooth muscle cells at sites distant from vascular injury. Arteriosclerosis. 1990;10:298-305.
32. Karas SP, Gravanis MB, Santoian EC, Robinson KA, Anderberg KA, King SB III. Coronary intimal proliferation after balloon injury and stenting in swine: an animal model of restenosis. J Am Coll Cardiol. 1992;20:467-474.
33. Robinson KA. Pig coronary artery model of post-angioplasty restenosis. In: Waksman R, ed. Vascular Brachytherapy. Veenendaal, Netherlands: Nucletron-Oldelft; 1997.
34. Willy C, Thiery J, Menger M, Messmer K, Arfors KE, Lehr HA. Impact of vitamin E supplement in standard laboratory animal diet on microvascular manifestation of ischemia/reperfusion injury. Free Radic Biol Med. 1995;19:919-926.
35. Lehr HA, Frei B, Olofsson AM, Carew TE, Arfors KE. Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E. Circulation. 1995;91:1525-1532.
36. Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest. 1982;47:412-426.
37. Wallace DC. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science. 1992;256:628-632.
38. Friedl HP, Till GO, Ryan US, Ward PA. Mediator-induced activation of xanthine oxidase in endothelial cells. FASEB J. 1989;3:2512-2518.
39. Arita H, Nakano T, Ohara O, Teraoka H. Activation of group 11 phospholipase A, gene via two distinct mechanisms in rat vascular smooth muscle cells. In: Samuelsson B, Paoletti R, Ramwell PW, Folco G Granstrom E, eds. Advances in Prostaglandin, Thromboxane, and Leukotriene Research. New York, NY: Raven Press Ltd; 1990;21:277-280.
40. Rao GN, Runge MS, Alexander RW. Hydrogen peroxide activation of cytosolic phospholipase A2 in vascular smooth muscle cells. Biochim Biophys Acta. 1995;1265:67-72.
41. Rao GN, Baas AS, Glasgow WC, Eling TE, Runge MS, Alexander RW Activation of mitogen-activated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells. J Biol Chem. 1994;269:32586-32591.
42. Rao GN, Lassegue B, Griendling KK, Alexander RW, Berk BC. Hydrogen peroxide-induced c-fos expression is mediated by arachidonic acid release: role of protein kinase C. Nucl Acids Res. 1993;21:1259-1263.
43. Burch HB. Methods for detecting and evaluating ascorbic acid deficiency in man and animals. Ann N Y Acad Sci. 1961;92:268-276.
44. Ferns GA, Forster L, Stewart LA, Konneh M, Nourooz ZJ, Anggard EE Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit Proc Natl Acad Sci U S A. 1992;89:11312-11316.
45. Daugherty A, Zweifel BS, Schonfeld G. The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits. Br J Pharmacol. 1991;103:1013-1018.
46. Willett WC, Stampfer MJ, Underwood BA, Taylor JO, Hennekens CH. Vitamins A, E, and carotene: effects of supplementation on their plasma levels. Am J Clin Nutr. 1983;38:559-566.
47. Hodis HN, Mack WJ, LaBree L, Cashin H-L, Sevanian A, Johnson R, Azen SP. Serial coronary angiographie evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA. 1995;273:1849-1854.
48. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-786.
49. Watanabe K, Sekiya M, Ikeda S, Miyagawa M, Hashida K. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty. Am Heart J. 1996;132:23-29.
50. Lee YJ Daida H, Yokoi H, Miyano H, Takaya J, Sakurai H, Mokuno H, Yamaguchi H. Effectiveness of probucol in preventing restenosis after percutaneous transluminal coronary angioplasty. Jpn Heart J. 1996;37:327-332.
51. O'Keefe JH Jr, Stone GW, McCallister BD Jr, Maddex C, Ligon R, Kacich RL, Kahn J, Cavero PG, Hartzler GO, McCallister BD. Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1996;77:649-652.